PR Newswire March 10, 2022

The collaboration will develop resources and educational materials to support life science companies with successfully engaging underrepresented populations in digitized clinical trials

BOSTON, March 10, 2022 /PRNewswire/ — The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.

Digital capabilities – from social media to the use of new technologies to measure disease outside of the clinic – offer enormous potential to fix the longstanding disparities in participation and access...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Clinical Trials, Pharma / Biotech, Trends
Related Articles:
Parexel strikes deal with Palantir for clinical trial AI
Risklick debuts new AI software that writes clinical trial protocols
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
It’s Time to Give Patients a Seat at the Table
LabConnect Agrees to Acquire A4P Consulting

Share This Article